Current Research Studies

Fontan Udenafil Exercise Longitudinal Assessment Trial (FUEL-2 Study)

FUEL-2

Phase: III
Clinicaltrials.gov ID: NCT05918211

What is the goal of the study?

To evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of phosphodiesterase type 5 (PDE5), versus placebo for the treatment of adolescent subjects who have undergone the Fontan procedure.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Matthew Files
Study Team Member: Ranjini Prakash, [email protected]